OrganizationField NameIDRequired
KCRCOVID-19 - BRM (COVID19BRM)

80104

yes
NAACCRCOVID TEXT RX -- BRM2660yes

Use the RX TEXT--BRM field to record information about BRM or immunotherapy delays, discontinuation, or modifications due to COVID-19.

CodeDescription
BRM DC D/T COVID-19

Immunotherapy was not performed due to COVID-19.

BRM CHG D/T COVID-19

Type of immounotherapy offered and performed was changed/modified from what is typically recommended due to COVID-19.

BRM DELAYED D/T COVID-19

Typical immunotherapy recommended was performed but it was delayed due to COVID-19.

BRM CHG & DELAYED D/T COVID-19Type of immounotherapy offered and performed was changed/modifieddue to COVID-19 and it was delayed.
BRM DELAYED D/T COVID-19 & GIVEN AS SUB TX AFTER PROGRESSION

Immunotherapy treatment was recommended before but administered after disease progression.

<blank>No change or delay of immunotherapy or bone marrow/stem cell transplant treatment due to COVID-19.

Note: Record the following information for all cancer patients (when applicable) regardless of whether or not they have a COVID-19 diagnosis or test.

  1. When medical documentation is available to indicate that immunotherapy administration was discontinued or not initiated because of COVID-19 pandemic, record
    1. BRM DC D/T COVID-19
  2. When medical documentation is available to indicate that immunotherapy administration was changed/modified (i.e. reduction in the number of cycles) because of COVID-19 pandemic, record
    1. BRM CHG D/T COVID-19
  3. When medical documentation is available to indicate that initiation of immunotherapy administration was delayed because of COVID-19 pandemic. record
    1. BRM DELAYED D/T COVID-19
  4. When medical documentation is available to indicate that immunotherapy administration was changed/modified (i.e. reduction in the number of cycles) and delayed because of COVID-19 pandemic, record
    1. BRM CHG & DELAYED D/T COVID-19
  5. When immunotherapy was recommended before but administered after disease progression, record
    1. BRM delayed D/T COVID-19 & given as subsequent TX after progression
    2. Note: Record BRM treatment in Second Course Rx fields